Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 11 hours ago • JNJ
Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?
Reuters • 1 day ago • JNJ
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
Reuters • 1 day ago • JNJ
U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
Seeking Alpha • 1 day ago • JNJ
Johnson & Johnson: Why I See Downside Ahead
Zacks Investment Research • 1 day ago • JNJ
5 Dividend Stocks Boost Payouts as Markets Reel Under Inflation Fears
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.